

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.37616979 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.73839185 |
| 3 | negative regulation of epidermis development (GO:0045683) | 7.32179926 |
| 4 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.20077767 |
| 5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.64979177 |
| 6 | somite rostral/caudal axis specification (GO:0032525) | 6.56721600 |
| 7 | intestinal absorption (GO:0050892) | 6.55598912 |
| 8 | maintenance of protein location in nucleus (GO:0051457) | 6.37509692 |
| 9 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.32757224 |
| 10 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.27313214 |
| 11 | NADH metabolic process (GO:0006734) | 6.13729868 |
| 12 | intestinal epithelial cell development (GO:0060576) | 6.11104366 |
| 13 | negative regulation of epidermal cell differentiation (GO:0045605) | 5.93243999 |
| 14 | muscle organ morphogenesis (GO:0048644) | 5.84468000 |
| 15 | positive regulation of respiratory burst (GO:0060267) | 5.83725012 |
| 16 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.72383805 |
| 17 | regulation of response to osmotic stress (GO:0047484) | 5.66332422 |
| 18 | protein localization to kinetochore (GO:0034501) | 5.62793978 |
| 19 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.62288833 |
| 20 | regulation of cellular extravasation (GO:0002691) | 5.59025913 |
| 21 | cytidine metabolic process (GO:0046087) | 5.46850012 |
| 22 | cytidine catabolic process (GO:0006216) | 5.46850012 |
| 23 | cytidine deamination (GO:0009972) | 5.46850012 |
| 24 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.36568257 |
| 25 | positive regulation of pseudopodium assembly (GO:0031274) | 5.32163014 |
| 26 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.20725100 |
| 27 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.16670151 |
| 28 | endocrine process (GO:0050886) | 5.16670151 |
| 29 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.16670151 |
| 30 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.15110184 |
| 31 | phenol-containing compound catabolic process (GO:0019336) | 5.14451872 |
| 32 | negative regulation of telomerase activity (GO:0051974) | 5.11508969 |
| 33 | histone H4-K8 acetylation (GO:0043982) | 5.07006375 |
| 34 | histone H4-K5 acetylation (GO:0043981) | 5.07006375 |
| 35 | hormone catabolic process (GO:0042447) | 5.06190461 |
| 36 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.05979620 |
| 37 | heterochromatin organization (GO:0070828) | 5.03492180 |
| 38 | rRNA transcription (GO:0009303) | 5.01076756 |
| 39 | antibacterial humoral response (GO:0019731) | 4.99550203 |
| 40 | histone H4-K12 acetylation (GO:0043983) | 4.96430415 |
| 41 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.93111281 |
| 42 | notochord development (GO:0030903) | 4.87185399 |
| 43 | renal system process involved in regulation of blood volume (GO:0001977) | 4.86573961 |
| 44 | antimicrobial humoral response (GO:0019730) | 4.84672869 |
| 45 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.76825209 |
| 46 | regulation of pseudopodium assembly (GO:0031272) | 4.76817601 |
| 47 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.74558505 |
| 48 | regulation of cGMP biosynthetic process (GO:0030826) | 4.70413483 |
| 49 | lipoprotein transport (GO:0042953) | 4.68828042 |
| 50 | regulation of systemic arterial blood pressure (GO:0003073) | 4.66066313 |
| 51 | vitamin A metabolic process (GO:0006776) | 4.65739573 |
| 52 | glomerular filtration (GO:0003094) | 4.59647421 |
| 53 | GDP-mannose metabolic process (GO:0019673) | 4.54661963 |
| 54 | mitotic sister chromatid segregation (GO:0000070) | 4.54515064 |
| 55 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.49636157 |
| 56 | regulation of vitamin metabolic process (GO:0030656) | 4.47728138 |
| 57 | regulation of cilium movement (GO:0003352) | 4.44968964 |
| 58 | cellular glucuronidation (GO:0052695) | 4.43840095 |
| 59 | fructose metabolic process (GO:0006000) | 4.38688058 |
| 60 | uronic acid metabolic process (GO:0006063) | 4.38618558 |
| 61 | glucuronate metabolic process (GO:0019585) | 4.38618558 |
| 62 | regulation of bile acid biosynthetic process (GO:0070857) | 4.36998325 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.31129675 |
| 64 | rRNA methylation (GO:0031167) | 4.29860121 |
| 65 | diacylglycerol metabolic process (GO:0046339) | 4.28398156 |
| 66 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.26340321 |
| 67 | urea cycle (GO:0000050) | 4.21190467 |
| 68 | renal filtration (GO:0097205) | 4.15956137 |
| 69 | regulation of respiratory burst (GO:0060263) | 4.13592136 |
| 70 | response to dietary excess (GO:0002021) | 4.13558376 |
| 71 | nucleoside transmembrane transport (GO:1901642) | 4.11071663 |
| 72 | protein localization to chromosome, centromeric region (GO:0071459) | 4.10016516 |
| 73 | cardiovascular system development (GO:0072358) | 4.09860906 |
| 74 | transepithelial transport (GO:0070633) | 4.09309528 |
| 75 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.09090878 |
| 76 | primitive streak formation (GO:0090009) | 4.04371086 |
| 77 | chromatin assembly (GO:0031497) | 4.04135975 |
| 78 | sulfate transmembrane transport (GO:1902358) | 4.03948850 |
| 79 | oligosaccharide biosynthetic process (GO:0009312) | 4.03662936 |
| 80 | interferon-gamma production (GO:0032609) | 4.03158626 |
| 81 | primary alcohol catabolic process (GO:0034310) | 4.00784341 |
| 82 | rRNA modification (GO:0000154) | 3.99674495 |
| 83 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.97750980 |
| 84 | urea metabolic process (GO:0019627) | 3.96435377 |
| 85 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.95341412 |
| 86 | quinone metabolic process (GO:1901661) | 3.91221964 |
| 87 | regulation of translation in response to stress (GO:0043555) | 3.89671938 |
| 88 | drug metabolic process (GO:0017144) | 3.87811530 |
| 89 | regulation of cGMP metabolic process (GO:0030823) | 3.87349007 |
| 90 | virion attachment to host cell (GO:0019062) | 3.86791429 |
| 91 | adhesion of symbiont to host cell (GO:0044650) | 3.86791429 |
| 92 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.86734950 |
| 93 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.84435931 |
| 94 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.81927953 |
| 95 | trophectodermal cell differentiation (GO:0001829) | 3.81755937 |
| 96 | cGMP-mediated signaling (GO:0019934) | 3.81332889 |
| 97 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.80670999 |
| 98 | ethanol oxidation (GO:0006069) | 3.78889376 |
| 99 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.73050037 |
| 100 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.73050037 |
| 101 | sister chromatid segregation (GO:0000819) | 3.73004179 |
| 102 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.68213333 |
| 103 | maintenance of protein localization in organelle (GO:0072595) | 3.68194614 |
| 104 | flavonoid metabolic process (GO:0009812) | 3.67269561 |
| 105 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.66480249 |
| 106 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.66473756 |
| 107 | epoxygenase P450 pathway (GO:0019373) | 3.66457216 |
| 108 | nitrogen cycle metabolic process (GO:0071941) | 3.66367691 |
| 109 | transcytosis (GO:0045056) | 3.66335957 |
| 110 | cellular modified amino acid catabolic process (GO:0042219) | 3.63669150 |
| 111 | histone H4-K16 acetylation (GO:0043984) | 3.62247862 |
| 112 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.61111587 |
| 113 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.59451980 |
| 114 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58944883 |
| 115 | vitamin transmembrane transport (GO:0035461) | 3.58167949 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 3.57282168 |
| 117 | mitochondrion distribution (GO:0048311) | 3.55771782 |
| 118 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.52675552 |
| 119 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.51549413 |
| 120 | coenzyme catabolic process (GO:0009109) | 3.51443927 |
| 121 | glycosphingolipid catabolic process (GO:0046479) | 3.51272750 |
| 122 | DNA replication checkpoint (GO:0000076) | 3.49669765 |
| 123 | negative regulation of telomere maintenance (GO:0032205) | 3.48986164 |
| 124 | nuclear pore complex assembly (GO:0051292) | 3.47583878 |
| 125 | glycolipid catabolic process (GO:0019377) | 3.46774523 |
| 126 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.46696234 |
| 127 | phenylpropanoid metabolic process (GO:0009698) | 3.46588632 |
| 128 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44402222 |
| 129 | thyroid hormone generation (GO:0006590) | 3.44319541 |
| 130 | arginine metabolic process (GO:0006525) | 3.42658760 |
| 131 | digestion (GO:0007586) | 3.42416251 |
| 132 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.42185959 |
| 133 | actin filament depolymerization (GO:0030042) | 3.41915990 |
| 134 | peptide catabolic process (GO:0043171) | 3.41582191 |
| 135 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.41057064 |
| 136 | glucocorticoid biosynthetic process (GO:0006704) | 3.40168653 |
| 137 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.39907981 |
| 138 | peptide hormone processing (GO:0016486) | 3.37802370 |
| 139 | proline transport (GO:0015824) | 3.36900066 |
| 140 | regulation of telomerase activity (GO:0051972) | 3.34510212 |
| 141 | complement activation, classical pathway (GO:0006958) | 3.33703877 |
| 142 | O-glycan processing (GO:0016266) | 3.33352901 |
| 143 | eosinophil chemotaxis (GO:0048245) | 3.32541079 |
| 144 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.31686064 |
| 145 | desmosome organization (GO:0002934) | 3.30520980 |
| 146 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.30444879 |
| 147 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30184106 |
| 148 | maternal placenta development (GO:0001893) | 3.29285875 |
| 149 | arachidonic acid secretion (GO:0050482) | 3.28584063 |
| 150 | icosanoid secretion (GO:0032309) | 3.28584063 |
| 151 | digestive system process (GO:0022600) | 3.27838124 |
| 152 | positive regulation of digestive system process (GO:0060456) | 3.26324526 |
| 153 | sulfate transport (GO:0008272) | 3.25398464 |
| 154 | adhesion of symbiont to host (GO:0044406) | 3.25337370 |
| 155 | hypotonic response (GO:0006971) | 3.24609438 |
| 156 | sulfur amino acid catabolic process (GO:0000098) | 3.23557503 |
| 157 | nucleoside transport (GO:0015858) | 3.23127382 |
| 158 | thyroid hormone metabolic process (GO:0042403) | 3.17264094 |
| 159 | microtubule severing (GO:0051013) | 3.15609232 |
| 160 | auditory receptor cell differentiation (GO:0042491) | 3.14720006 |
| 161 | omega-hydroxylase P450 pathway (GO:0097267) | 3.13880103 |
| 162 | bone trabecula formation (GO:0060346) | 3.13213892 |
| 163 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.11765746 |
| 164 | epithelial structure maintenance (GO:0010669) | 3.10910479 |
| 165 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.10793964 |
| 166 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.10170886 |
| 167 | labyrinthine layer development (GO:0060711) | 3.10071438 |
| 168 | mRNA stabilization (GO:0048255) | 3.09848620 |
| 169 | RNA stabilization (GO:0043489) | 3.09848620 |
| 170 | positive regulation of protein deacetylation (GO:0090312) | 3.09405807 |
| 171 | detection of temperature stimulus (GO:0016048) | 3.08791631 |
| 172 | apoptotic DNA fragmentation (GO:0006309) | 3.07043801 |
| 173 | retinoic acid receptor signaling pathway (GO:0048384) | 3.06127585 |
| 174 | tachykinin receptor signaling pathway (GO:0007217) | 3.02898088 |
| 175 | transcription from mitochondrial promoter (GO:0006390) | 3.02557495 |
| 176 | DNA damage response, detection of DNA damage (GO:0042769) | 3.02064255 |
| 177 | vitamin transport (GO:0051180) | 3.01813211 |
| 178 | receptor recycling (GO:0001881) | 3.00208432 |
| 179 | regulation of epidermis development (GO:0045682) | 3.00065104 |
| 180 | fucosylation (GO:0036065) | 2.97963295 |
| 181 | sphingomyelin metabolic process (GO:0006684) | 2.97898980 |
| 182 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.97307554 |
| 183 | eosinophil migration (GO:0072677) | 2.94508327 |
| 184 | alkaloid metabolic process (GO:0009820) | 2.94449335 |
| 185 | response to nitric oxide (GO:0071731) | 2.94249090 |
| 186 | glycosylceramide metabolic process (GO:0006677) | 2.92756942 |
| 187 | cGMP biosynthetic process (GO:0006182) | 2.91928064 |
| 188 | ethanol metabolic process (GO:0006067) | 2.91874975 |
| 189 | thrombin receptor signaling pathway (GO:0070493) | 2.90430015 |
| 190 | plasma lipoprotein particle assembly (GO:0034377) | 2.88918995 |
| 191 | sphingolipid catabolic process (GO:0030149) | 2.87821930 |
| 192 | sulfur compound transport (GO:0072348) | 2.87610112 |
| 193 | cellular response to nitric oxide (GO:0071732) | 2.85867702 |
| 194 | polyketide metabolic process (GO:0030638) | 10.3734248 |
| 195 | doxorubicin metabolic process (GO:0044598) | 10.3734248 |
| 196 | daunorubicin metabolic process (GO:0044597) | 10.3734248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.60367761 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.60367761 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.60367761 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.31878848 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.91321036 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.73859252 |
| 7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.59168656 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.44100169 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.34185787 |
| 10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.24445111 |
| 11 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.97140074 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.87446451 |
| 13 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.85227493 |
| 14 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.81046733 |
| 15 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.72430621 |
| 16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.64503076 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.64096337 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54593898 |
| 19 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.53068428 |
| 20 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.52972110 |
| 21 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.46084887 |
| 22 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.43882162 |
| 23 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.42342283 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.42129780 |
| 25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37913943 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.37829098 |
| 27 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.19605776 |
| 28 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13785968 |
| 29 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.08280911 |
| 30 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.07179910 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03391905 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.02288903 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00265406 |
| 34 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99766511 |
| 35 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.99589487 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.97301385 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.96582588 |
| 38 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.92347459 |
| 39 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.91005986 |
| 40 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.89200417 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76469775 |
| 42 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.76379798 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.74084700 |
| 44 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.71930046 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65843688 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64911271 |
| 47 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.63240236 |
| 48 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.62337174 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.61047715 |
| 50 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.59716479 |
| 51 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59491105 |
| 52 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.58763824 |
| 53 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56120521 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55597354 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.53676928 |
| 56 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.52987856 |
| 57 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.52867622 |
| 58 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.52493134 |
| 59 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.50907134 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50261612 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49112330 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.48926838 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46707525 |
| 64 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46334307 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.45100992 |
| 66 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.43743058 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42998660 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40884777 |
| 69 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.38721394 |
| 70 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.37943313 |
| 71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34422693 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33492456 |
| 73 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33162909 |
| 74 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.32677923 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32024270 |
| 76 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.31916506 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.30474259 |
| 78 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.28599230 |
| 79 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.27975972 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26812527 |
| 81 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.24555704 |
| 82 | SA1_27219007_Chip-Seq_Bcells_Human | 1.23714754 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23161474 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22305568 |
| 85 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.21126407 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20302697 |
| 87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19178637 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18580450 |
| 89 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.17921818 |
| 90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.17831253 |
| 91 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13437709 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13107879 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12878175 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12744571 |
| 95 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12144802 |
| 96 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.11648807 |
| 97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11479835 |
| 98 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08397890 |
| 99 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06919070 |
| 100 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05712643 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05327232 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04901465 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04068515 |
| 104 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.03994268 |
| 105 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.03964447 |
| 106 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.02521154 |
| 107 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.02476409 |
| 108 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.01834504 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01547676 |
| 110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99746564 |
| 111 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99615885 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.99251701 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98980803 |
| 114 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98626936 |
| 115 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98418535 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97307493 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97243711 |
| 118 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96667643 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95333819 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94649090 |
| 121 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.94392251 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94377582 |
| 123 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94143148 |
| 124 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94129106 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92731794 |
| 126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92000953 |
| 127 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91973061 |
| 128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91854147 |
| 129 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91539053 |
| 130 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.91122882 |
| 131 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91058274 |
| 132 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.90481619 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90171877 |
| 134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88914252 |
| 135 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.88715876 |
| 136 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88673218 |
| 137 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88636004 |
| 138 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88506873 |
| 139 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.87888784 |
| 140 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87880109 |
| 141 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87391227 |
| 142 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.87272936 |
| 143 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86946813 |
| 144 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.86834928 |
| 145 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.86625264 |
| 146 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84224099 |
| 147 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.84155961 |
| 148 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.84022734 |
| 149 | MYC_22102868_ChIP-Seq_BL_Human | 0.83678854 |
| 150 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.82774634 |
| 151 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.80200414 |
| 152 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.80086666 |
| 153 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.79140789 |
| 154 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.77985094 |
| 155 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76264032 |
| 156 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.75952972 |
| 157 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.75800657 |
| 158 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.75672384 |
| 159 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75216841 |
| 160 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.74554671 |
| 161 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74300979 |
| 162 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.72968484 |
| 163 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.72895533 |
| 164 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72287969 |
| 165 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.71700327 |
| 166 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.70162237 |
| 167 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.69388852 |
| 168 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.69228044 |
| 169 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.68694010 |
| 170 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.68661012 |
| 171 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68269474 |
| 172 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.68065767 |
| 173 | P68_20966046_ChIP-Seq_HELA_Human | 0.66749615 |
| 174 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.66535872 |
| 175 | ATF3_27146783_Chip-Seq_COLON_Human | 0.66528323 |
| 176 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.65281325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 6.91698532 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 5.61780700 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.92511339 |
| 4 | MP0003011_delayed_dark_adaptation | 4.26867983 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.82214046 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.78207944 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.75360477 |
| 8 | MP0006292_abnormal_olfactory_placode | 3.44082649 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 3.16460034 |
| 10 | MP0004858_abnormal_nervous_system | 3.15841209 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 3.02205535 |
| 12 | MP0005499_abnormal_olfactory_system | 2.96834866 |
| 13 | MP0005394_taste/olfaction_phenotype | 2.96834866 |
| 14 | MP0005365_abnormal_bile_salt | 2.92852131 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.87991903 |
| 16 | MP0004147_increased_porphyrin_level | 2.85752320 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.71211110 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 2.64152018 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.59491336 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.51738345 |
| 21 | MP0008057_abnormal_DNA_replication | 2.49706548 |
| 22 | MP0009840_abnormal_foam_cell | 2.43791414 |
| 23 | MP0001664_abnormal_digestion | 2.42651232 |
| 24 | MP0003122_maternal_imprinting | 2.30640052 |
| 25 | MP0005257_abnormal_intraocular_pressure | 2.30415571 |
| 26 | MP0003183_abnormal_peptide_metabolism | 2.20128283 |
| 27 | MP0005409_darkened_coat_color | 2.14317239 |
| 28 | MP0002332_abnormal_exercise_endurance | 2.07299918 |
| 29 | MP0001348_abnormal_lacrimal_gland | 2.02882573 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 2.00625775 |
| 31 | MP0003283_abnormal_digestive_organ | 1.95912729 |
| 32 | MP0003868_abnormal_feces_composition | 1.93689345 |
| 33 | MP0001849_ear_inflammation | 1.88275910 |
| 34 | MP0003121_genomic_imprinting | 1.88251908 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.87507834 |
| 36 | MP0000490_abnormal_crypts_of | 1.86880972 |
| 37 | MP0001663_abnormal_digestive_system | 1.86198637 |
| 38 | MP0001765_abnormal_ion_homeostasis | 1.78275462 |
| 39 | MP0003123_paternal_imprinting | 1.76847232 |
| 40 | MP0005166_decreased_susceptibility_to | 1.75164477 |
| 41 | MP0006082_CNS_inflammation | 1.74226272 |
| 42 | MP0002653_abnormal_ependyma_morphology | 1.74195157 |
| 43 | MP0003938_abnormal_ear_development | 1.70846499 |
| 44 | MP0003315_abnormal_perineum_morphology | 1.64727189 |
| 45 | MP0005381_digestive/alimentary_phenotyp | 1.63685824 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.58595602 |
| 47 | MP0010030_abnormal_orbit_morphology | 1.54848030 |
| 48 | MP0000762_abnormal_tongue_morphology | 1.50877293 |
| 49 | MP0005380_embryogenesis_phenotype | 1.46821801 |
| 50 | MP0001672_abnormal_embryogenesis/_devel | 1.46821801 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.43805662 |
| 52 | MP0004043_abnormal_pH_regulation | 1.43085122 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.40656375 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.38325299 |
| 55 | MP0002088_abnormal_embryonic_growth/wei | 1.36420882 |
| 56 | MP0005332_abnormal_amino_acid | 1.36021787 |
| 57 | MP0000537_abnormal_urethra_morphology | 1.34789821 |
| 58 | MP0003984_embryonic_growth_retardation | 1.34230606 |
| 59 | MP0005451_abnormal_body_composition | 1.33950778 |
| 60 | MP0001188_hyperpigmentation | 1.33694689 |
| 61 | MP0003879_abnormal_hair_cell | 1.29036458 |
| 62 | MP0005670_abnormal_white_adipose | 1.28791727 |
| 63 | MP0008961_abnormal_basal_metabolism | 1.28030904 |
| 64 | MP0005266_abnormal_metabolism | 1.26533045 |
| 65 | MP0001764_abnormal_homeostasis | 1.20630698 |
| 66 | MP0003724_increased_susceptibility_to | 1.20180502 |
| 67 | MP0000049_abnormal_middle_ear | 1.19596974 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.19134618 |
| 69 | MP0002127_abnormal_cardiovascular_syste | 1.18739995 |
| 70 | MP0000350_abnormal_cell_proliferation | 1.17625734 |
| 71 | MP0002136_abnormal_kidney_physiology | 1.17597031 |
| 72 | MP0003252_abnormal_bile_duct | 1.17429276 |
| 73 | MP0008004_abnormal_stomach_pH | 1.17244852 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.16513234 |
| 75 | MP0005310_abnormal_salivary_gland | 1.15611018 |
| 76 | MP0000538_abnormal_urinary_bladder | 1.14405692 |
| 77 | MP0000477_abnormal_intestine_morphology | 1.14001838 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.09207232 |
| 79 | MP0001873_stomach_inflammation | 1.07366736 |
| 80 | MP0008789_abnormal_olfactory_epithelium | 1.06099249 |
| 81 | MP0003119_abnormal_digestive_system | 1.05336818 |
| 82 | MP0002233_abnormal_nose_morphology | 1.05139251 |
| 83 | MP0002092_abnormal_eye_morphology | 1.03807642 |
| 84 | MP0001293_anophthalmia | 1.03096704 |
| 85 | MP0003303_peritoneal_inflammation | 1.01273044 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 1.01117070 |
| 87 | * MP0002086_abnormal_extraembryonic_tissu | 1.00770635 |
| 88 | MP0001756_abnormal_urination | 1.00167204 |
| 89 | MP0008872_abnormal_physiological_respon | 0.99494405 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.95341094 |
| 91 | MP0002085_abnormal_embryonic_tissue | 0.93661224 |
| 92 | MP0005248_abnormal_Harderian_gland | 0.93457827 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.92628193 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.92411057 |
| 95 | MP0003693_abnormal_embryo_hatching | 0.90514573 |
| 96 | MP0002796_impaired_skin_barrier | 0.90497529 |
| 97 | MP0005501_abnormal_skin_physiology | 0.90083263 |
| 98 | MP0003787_abnormal_imprinting | 0.90018913 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.89560622 |
| 100 | MP0002132_abnormal_respiratory_system | 0.88710114 |
| 101 | MP0002970_abnormal_white_adipose | 0.88450123 |
| 102 | MP0002396_abnormal_hematopoietic_system | 0.87686247 |
| 103 | MP0009785_altered_susceptibility_to | 0.87403728 |
| 104 | MP0002822_catalepsy | 0.86264950 |
| 105 | MP0003300_gastrointestinal_ulcer | 0.83632503 |
| 106 | MP0003077_abnormal_cell_cycle | 0.83597083 |
| 107 | MP0003137_abnormal_impulse_conducting | 0.83574123 |
| 108 | MP0000462_abnormal_digestive_system | 0.83412252 |
| 109 | MP0000432_abnormal_head_morphology | 0.82932652 |
| 110 | MP0000609_abnormal_liver_physiology | 0.81686509 |
| 111 | MP0005025_abnormal_response_to | 0.80264078 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.80124758 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79909102 |
| 114 | * MP0002932_abnormal_joint_morphology | 0.79901246 |
| 115 | MP0003329_amyloid_beta_deposits | 0.77536652 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.75896640 |
| 117 | MP0003191_abnormal_cellular_cholesterol | 0.75767770 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.75649005 |
| 119 | MP0000383_abnormal_hair_follicle | 0.75489740 |
| 120 | MP0001501_abnormal_sleep_pattern | 0.75437550 |
| 121 | MP0002971_abnormal_brown_adipose | 0.75191845 |
| 122 | * MP0002114_abnormal_axial_skeleton | 0.74703415 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.74663363 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.73941970 |
| 125 | MP0000428_abnormal_craniofacial_morphol | 0.73866962 |
| 126 | MP0004947_skin_inflammation | 0.73336812 |
| 127 | MP0005448_abnormal_energy_balance | 0.73322941 |
| 128 | MP0009333_abnormal_splenocyte_physiolog | 0.72339195 |
| 129 | MP0009115_abnormal_fat_cell | 0.72084705 |
| 130 | MP0003755_abnormal_palate_morphology | 0.71994237 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.71715884 |
| 132 | MP0002084_abnormal_developmental_patter | 0.71427497 |
| 133 | MP0000566_synostosis | 0.71072563 |
| 134 | MP0003436_decreased_susceptibility_to | 0.70376473 |
| 135 | MP0000313_abnormal_cell_death | 0.70376124 |
| 136 | MP0001790_abnormal_immune_system | 0.69982303 |
| 137 | MP0005387_immune_system_phenotype | 0.69982303 |
| 138 | MP0008770_decreased_survivor_rate | 0.68051646 |
| 139 | MP0002006_tumorigenesis | 0.67925038 |
| 140 | MP0000613_abnormal_salivary_gland | 0.67835322 |
| 141 | MP0001835_abnormal_antigen_presentation | 0.67119487 |
| 142 | MP0001730_embryonic_growth_arrest | 0.67029863 |
| 143 | MP0004381_abnormal_hair_follicle | 0.65881647 |
| 144 | MP0000377_abnormal_hair_follicle | 0.65851010 |
| 145 | MP0003935_abnormal_craniofacial_develop | 0.61589341 |
| 146 | MP0002009_preneoplasia | 0.61366457 |
| 147 | MP0005360_urolithiasis | 0.60775846 |
| 148 | MP0003866_abnormal_defecation | 0.60376002 |
| 149 | MP0005165_increased_susceptibility_to | 0.60247417 |
| 150 | MP0004782_abnormal_surfactant_physiolog | 0.59997775 |
| 151 | MP0002148_abnormal_hypersensitivity_rea | 0.59789634 |
| 152 | MP0003718_maternal_effect | 0.59667328 |
| 153 | MP0005023_abnormal_wound_healing | 0.59541413 |
| 154 | MP0003111_abnormal_nucleus_morphology | 0.59086022 |
| 155 | MP0001216_abnormal_epidermal_layer | 0.57308730 |
| 156 | MP0004133_heterotaxia | 0.56978265 |
| 157 | MP0001697_abnormal_embryo_size | 0.56797062 |
| 158 | MP0000604_amyloidosis | 0.56713889 |
| 159 | MP0004270_analgesia | 0.56660823 |
| 160 | MP0005319_abnormal_enzyme/_coenzyme | 0.56618732 |
| 161 | MP0004197_abnormal_fetal_growth/weight/ | 0.56568278 |
| 162 | MP0008469_abnormal_protein_level | 0.56158229 |
| 163 | MP0002998_abnormal_bone_remodeling | 0.56061374 |
| 164 | MP0009642_abnormal_blood_homeostasis | 0.56061032 |
| 165 | MP0002876_abnormal_thyroid_physiology | 0.54835023 |
| 166 | MP0003806_abnormal_nucleotide_metabolis | 0.52975295 |
| 167 | MP0002751_abnormal_autonomic_nervous | 0.52880251 |
| 168 | MP0005391_vision/eye_phenotype | 0.52830051 |
| 169 | MP0002080_prenatal_lethality | 0.51660463 |
| 170 | MP0005376_homeostasis/metabolism_phenot | 0.51207129 |
| 171 | MP0002249_abnormal_larynx_morphology | 0.50910026 |
| 172 | MP0002925_abnormal_cardiovascular_devel | 0.50739317 |
| 173 | MP0002111_abnormal_tail_morphology | 0.50451717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.12387599 |
| 2 | Bilateral microphthalmos (HP:0007633) | 7.55269151 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 6.13510022 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 5.97229610 |
| 5 | Multiple enchondromatosis (HP:0005701) | 5.59474800 |
| 6 | Metabolic alkalosis (HP:0200114) | 5.51542211 |
| 7 | Decreased circulating renin level (HP:0003351) | 5.45818582 |
| 8 | Hepatoblastoma (HP:0002884) | 5.40930588 |
| 9 | Abnormality of proline metabolism (HP:0010907) | 5.35586085 |
| 10 | Hydroxyprolinuria (HP:0003080) | 5.35586085 |
| 11 | Abnormality of renin-angiotensin system (HP:0000847) | 4.91829112 |
| 12 | Rib fusion (HP:0000902) | 4.51230448 |
| 13 | Alkalosis (HP:0001948) | 4.50369226 |
| 14 | Chronic diarrhea (HP:0002028) | 4.50083134 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.40559740 |
| 16 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.25551733 |
| 17 | Abnormality of the lower motor neuron (HP:0002366) | 4.16151831 |
| 18 | Ependymoma (HP:0002888) | 4.00131183 |
| 19 | Abnormality of vitamin B metabolism (HP:0004340) | 3.94596592 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.72953859 |
| 21 | Trismus (HP:0000211) | 3.70249172 |
| 22 | Flat acetabular roof (HP:0003180) | 3.69079947 |
| 23 | Fat malabsorption (HP:0002630) | 3.68846456 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 3.63724999 |
| 25 | Widely patent fontanelles and sutures (HP:0004492) | 3.63132630 |
| 26 | Abdominal distention (HP:0003270) | 3.58148751 |
| 27 | Testicular atrophy (HP:0000029) | 3.52887639 |
| 28 | Partial duplication of thumb phalanx (HP:0009944) | 3.50732763 |
| 29 | Neoplasm of striated muscle (HP:0009728) | 3.39477920 |
| 30 | Ragged-red muscle fibers (HP:0003200) | 3.33860918 |
| 31 | Confusion (HP:0001289) | 3.33760060 |
| 32 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.32577179 |
| 33 | Rhabdomyosarcoma (HP:0002859) | 3.29914610 |
| 34 | Villous atrophy (HP:0011473) | 3.29733046 |
| 35 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.29733046 |
| 36 | Abnormal cartilage morphology (HP:0002763) | 3.29467102 |
| 37 | Congenital sensorineural hearing impairment (HP:0008527) | 3.27131772 |
| 38 | Fused cervical vertebrae (HP:0002949) | 3.20462762 |
| 39 | Abnormality of vitamin metabolism (HP:0100508) | 3.18925713 |
| 40 | Hypobetalipoproteinemia (HP:0003563) | 3.18300928 |
| 41 | Hypoplasia of the fovea (HP:0007750) | 3.15913493 |
| 42 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.15913493 |
| 43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.15905188 |
| 44 | Reduced antithrombin III activity (HP:0001976) | 3.15426968 |
| 45 | Abnormality of the salivary glands (HP:0010286) | 3.12246967 |
| 46 | Malnutrition (HP:0004395) | 3.11810296 |
| 47 | Abnormality of chloride homeostasis (HP:0011422) | 3.08515920 |
| 48 | Hemorrhage of the eye (HP:0011885) | 3.08350102 |
| 49 | Rectal fistula (HP:0100590) | 3.07422910 |
| 50 | Rectovaginal fistula (HP:0000143) | 3.07422910 |
| 51 | Embryonal renal neoplasm (HP:0011794) | 3.05953378 |
| 52 | Short humerus (HP:0005792) | 3.04676748 |
| 53 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.03988873 |
| 54 | Partial duplication of the phalanx of hand (HP:0009999) | 3.03612467 |
| 55 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.01600477 |
| 56 | Thin bony cortex (HP:0002753) | 2.98871320 |
| 57 | Hyperaldosteronism (HP:0000859) | 2.94856786 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.91727157 |
| 59 | Acanthocytosis (HP:0001927) | 2.87320341 |
| 60 | Hyperparathyroidism (HP:0000843) | 2.82850646 |
| 61 | Wide cranial sutures (HP:0010537) | 2.80701505 |
| 62 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.80052316 |
| 63 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.77561090 |
| 64 | Astrocytoma (HP:0009592) | 2.76383441 |
| 65 | Abnormality of the astrocytes (HP:0100707) | 2.76383441 |
| 66 | Hypokalemia (HP:0002900) | 2.74435994 |
| 67 | Cheilitis (HP:0100825) | 2.74140947 |
| 68 | Nausea (HP:0002018) | 2.73779434 |
| 69 | Intestinal fistula (HP:0100819) | 2.71905400 |
| 70 | Eczematoid dermatitis (HP:0000976) | 2.71109268 |
| 71 | Hyperglycinuria (HP:0003108) | 2.70228524 |
| 72 | Bifid tongue (HP:0010297) | 2.69167774 |
| 73 | Anomalous pulmonary venous return (HP:0010772) | 2.68631466 |
| 74 | Chromsome breakage (HP:0040012) | 2.67622888 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 2.66911338 |
| 76 | Glycosuria (HP:0003076) | 2.66911338 |
| 77 | Vaginal fistula (HP:0004320) | 2.66710474 |
| 78 | Abnormal lung lobation (HP:0002101) | 2.64708776 |
| 79 | Pili torti (HP:0003777) | 2.63883421 |
| 80 | Periauricular skin pits (HP:0100277) | 2.62654150 |
| 81 | Preauricular pit (HP:0004467) | 2.62654150 |
| 82 | Tongue fasciculations (HP:0001308) | 2.61674714 |
| 83 | Sensory axonal neuropathy (HP:0003390) | 2.61220839 |
| 84 | Horizontal nystagmus (HP:0000666) | 2.60226379 |
| 85 | Amyotrophic lateral sclerosis (HP:0007354) | 2.59370333 |
| 86 | Abnormal tarsal ossification (HP:0008369) | 2.57918568 |
| 87 | Glomerulonephritis (HP:0000099) | 2.53822928 |
| 88 | Microretrognathia (HP:0000308) | 2.53534341 |
| 89 | Nephrolithiasis (HP:0000787) | 2.52641516 |
| 90 | Hyperammonemia (HP:0001987) | 2.52226302 |
| 91 | Preauricular skin tag (HP:0000384) | 2.51722335 |
| 92 | Large earlobe (HP:0009748) | 2.50642668 |
| 93 | Hypochromic anemia (HP:0001931) | 2.48837218 |
| 94 | Intrahepatic cholestasis (HP:0001406) | 2.45955287 |
| 95 | Upper limb muscle weakness (HP:0003484) | 2.44866243 |
| 96 | Pigmentary retinal degeneration (HP:0001146) | 2.44800167 |
| 97 | Abnormality of complement system (HP:0005339) | 2.43505160 |
| 98 | Progressive muscle weakness (HP:0003323) | 2.43446860 |
| 99 | Renal tubular acidosis (HP:0001947) | 2.39547297 |
| 100 | Hypophosphatemia (HP:0002148) | 2.38807599 |
| 101 | Shawl scrotum (HP:0000049) | 2.38393590 |
| 102 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.36913109 |
| 103 | Abnormality of glycine metabolism (HP:0010895) | 2.36913109 |
| 104 | Abnormality of potassium homeostasis (HP:0011042) | 2.36777415 |
| 105 | Xanthomatosis (HP:0000991) | 2.35883840 |
| 106 | Muscle fibrillation (HP:0010546) | 2.33399367 |
| 107 | Nasolacrimal duct obstruction (HP:0000579) | 2.33128913 |
| 108 | Abnormality of the pulmonary veins (HP:0011718) | 2.32607656 |
| 109 | Hypotension (HP:0002615) | 2.32269666 |
| 110 | Hyponatremia (HP:0002902) | 2.32013505 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 2.31848899 |
| 112 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31848899 |
| 113 | Short 5th finger (HP:0009237) | 2.30181988 |
| 114 | Increased purine levels (HP:0004368) | 2.29297607 |
| 115 | Hyperuricemia (HP:0002149) | 2.29297607 |
| 116 | Aplastic anemia (HP:0001915) | 2.28767005 |
| 117 | Increased connective tissue (HP:0009025) | 2.28616976 |
| 118 | Abnormality of the fovea (HP:0000493) | 2.28257664 |
| 119 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27913676 |
| 120 | Delayed epiphyseal ossification (HP:0002663) | 2.27792535 |
| 121 | Complement deficiency (HP:0004431) | 2.26708597 |
| 122 | Pendular nystagmus (HP:0012043) | 2.24369240 |
| 123 | Impulsivity (HP:0100710) | 2.22593773 |
| 124 | Posterior subcapsular cataract (HP:0007787) | 2.21151011 |
| 125 | Micronodular cirrhosis (HP:0001413) | 2.20791202 |
| 126 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19536167 |
| 127 | Hyperphosphatemia (HP:0002905) | 2.18309798 |
| 128 | Abnormal hair laboratory examination (HP:0003328) | 2.17621672 |
| 129 | Nephritis (HP:0000123) | 2.17619918 |
| 130 | Skin tags (HP:0010609) | 2.17398476 |
| 131 | Glossoptosis (HP:0000162) | 2.16958083 |
| 132 | Focal segmental glomerulosclerosis (HP:0000097) | 2.16939591 |
| 133 | Hyperventilation (HP:0002883) | 2.15334821 |
| 134 | Abnormal biliary tract morphology (HP:0012440) | 2.14766429 |
| 135 | Skin pits (HP:0100276) | 2.11434777 |
| 136 | Ileus (HP:0002595) | 2.10745440 |
| 137 | Tetraplegia (HP:0002445) | 2.09744868 |
| 138 | Flattened epiphyses (HP:0003071) | 2.08873200 |
| 139 | Megaloblastic anemia (HP:0001889) | 2.07690764 |
| 140 | Difficulty running (HP:0009046) | 2.07229194 |
| 141 | Meckel diverticulum (HP:0002245) | 2.07074499 |
| 142 | Abnormality of the pubic bones (HP:0003172) | 2.06900561 |
| 143 | Cerebral palsy (HP:0100021) | 2.06603691 |
| 144 | Steatorrhea (HP:0002570) | 2.06518489 |
| 145 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.06506477 |
| 146 | Growth hormone excess (HP:0000845) | 2.06287446 |
| 147 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.05693826 |
| 148 | Syncope (HP:0001279) | 2.05503020 |
| 149 | Abnormality of magnesium homeostasis (HP:0004921) | 2.04682161 |
| 150 | Renal duplication (HP:0000075) | 2.04087685 |
| 151 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.03844878 |
| 152 | Abnormality of the musculature of the hand (HP:0001421) | 2.03650975 |
| 153 | Supernumerary spleens (HP:0009799) | 2.00070806 |
| 154 | Combined immunodeficiency (HP:0005387) | 1.99026285 |
| 155 | Gastrointestinal dysmotility (HP:0002579) | 1.97985693 |
| 156 | Enlarged epiphyses (HP:0010580) | 1.97413738 |
| 157 | Neoplasm of the heart (HP:0100544) | 1.97387114 |
| 158 | Abnormality of nucleobase metabolism (HP:0010932) | 1.96435644 |
| 159 | Protuberant abdomen (HP:0001538) | 1.96324160 |
| 160 | Glioma (HP:0009733) | 1.96296233 |
| 161 | Generalized hypotonia (HP:0001290) | 1.96186067 |
| 162 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.95926260 |
| 163 | Abnormality of the costochondral junction (HP:0000919) | 1.95598373 |
| 164 | Fasciculations (HP:0002380) | 1.95369752 |
| 165 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.94303648 |
| 166 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.93805066 |
| 167 | Visceral angiomatosis (HP:0100761) | 1.93753182 |
| 168 | Dehydration (HP:0001944) | 1.93343585 |
| 169 | Ventricular fibrillation (HP:0001663) | 1.93252697 |
| 170 | Hypoplastic scapulae (HP:0000882) | 1.93101427 |
| 171 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.93101427 |
| 172 | Abnormality of purine metabolism (HP:0004352) | 1.93039745 |
| 173 | Pancreatitis (HP:0001733) | 1.93016860 |
| 174 | Type I transferrin isoform profile (HP:0003642) | 1.92316218 |
| 175 | Biliary tract neoplasm (HP:0100574) | 1.90788459 |
| 176 | Abnormality of the ileum (HP:0001549) | 1.90740566 |
| 177 | Pseudobulbar signs (HP:0002200) | 1.90649875 |
| 178 | Petechiae (HP:0000967) | 1.90280423 |
| 179 | Abnormal urine phosphate concentration (HP:0012599) | 1.89879126 |
| 180 | Microvesicular hepatic steatosis (HP:0001414) | 1.89065603 |
| 181 | Metabolic acidosis (HP:0001942) | 1.88860326 |
| 182 | Symptomatic seizures (HP:0011145) | 1.88529797 |
| 183 | Angiofibromas (HP:0010615) | 1.88220999 |
| 184 | Adenoma sebaceum (HP:0009720) | 1.88220999 |
| 185 | Hyperphosphaturia (HP:0003109) | 1.87393420 |
| 186 | Abnormality of chromosome segregation (HP:0002916) | 1.87117934 |
| 187 | Abnormality of carpal bone ossification (HP:0006257) | 1.87075685 |
| 188 | Increased serum pyruvate (HP:0003542) | 1.86968166 |
| 189 | Abnormality of glycolysis (HP:0004366) | 1.86968166 |
| 190 | Ventricular tachycardia (HP:0004756) | 1.86952180 |
| 191 | Potter facies (HP:0002009) | 1.86818718 |
| 192 | Facial shape deformation (HP:0011334) | 1.86818718 |
| 193 | Neonatal short-limb short stature (HP:0008921) | 1.79626142 |
| 194 | Abnormality of the 1st metacarpal (HP:0010009) | 1.79230208 |
| 195 | Curly hair (HP:0002212) | 1.78891481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.40314187 |
| 2 | ACVR1B | 6.59051872 |
| 3 | GRK5 | 5.16336874 |
| 4 | ERN1 | 4.73538034 |
| 5 | GRK6 | 4.49667413 |
| 6 | GRK1 | 3.27010913 |
| 7 | PIK3CA | 3.08912994 |
| 8 | ADRBK2 | 2.86110180 |
| 9 | STK39 | 2.78162635 |
| 10 | TTK | 2.72274325 |
| 11 | MATK | 2.61958282 |
| 12 | CSF1R | 2.59693536 |
| 13 | TYRO3 | 2.51503543 |
| 14 | TGFBR2 | 2.32511370 |
| 15 | STK10 | 2.27579702 |
| 16 | GRK7 | 2.22007178 |
| 17 | PRKG2 | 2.21899384 |
| 18 | OXSR1 | 2.14428694 |
| 19 | MAPK7 | 2.03389902 |
| 20 | WNK1 | 1.87324578 |
| 21 | MOS | 1.83655943 |
| 22 | PTK6 | 1.82201077 |
| 23 | FGFR4 | 1.79919479 |
| 24 | EPHA2 | 1.69967173 |
| 25 | TESK2 | 1.68265870 |
| 26 | STK24 | 1.52318805 |
| 27 | NTRK1 | 1.45604662 |
| 28 | CDK7 | 1.44742260 |
| 29 | PAK4 | 1.41001072 |
| 30 | CAMK4 | 1.33828641 |
| 31 | MYLK | 1.32724437 |
| 32 | MAP2K6 | 1.29542117 |
| 33 | MAP3K12 | 1.27600729 |
| 34 | TYK2 | 1.26082539 |
| 35 | PDK2 | 1.25477277 |
| 36 | LMTK2 | 1.24349249 |
| 37 | TESK1 | 1.20349726 |
| 38 | PRPF4B | 1.20194547 |
| 39 | MAP3K2 | 1.18831413 |
| 40 | MST4 | 1.18820784 |
| 41 | MAP3K1 | 1.16157707 |
| 42 | MAP3K10 | 1.15121939 |
| 43 | AKT3 | 1.14915805 |
| 44 | EPHB1 | 1.14187897 |
| 45 | MAP4K1 | 1.14076646 |
| 46 | NME1 | 1.07780401 |
| 47 | WNK4 | 1.06861285 |
| 48 | CHEK2 | 1.03409954 |
| 49 | MAP3K7 | 1.02706106 |
| 50 | EPHA3 | 1.00309048 |
| 51 | ADRBK1 | 0.98864061 |
| 52 | FGFR3 | 0.98309324 |
| 53 | PLK1 | 0.94523955 |
| 54 | CDC42BPA | 0.93652880 |
| 55 | HIPK2 | 0.93375051 |
| 56 | RIPK4 | 0.89760173 |
| 57 | MARK2 | 0.89480821 |
| 58 | MAP2K2 | 0.86963773 |
| 59 | CSK | 0.86814685 |
| 60 | CDK19 | 0.85316554 |
| 61 | PDPK1 | 0.84225439 |
| 62 | MAP2K4 | 0.83693454 |
| 63 | PRKCI | 0.83395101 |
| 64 | SMG1 | 0.74326767 |
| 65 | LATS1 | 0.73164013 |
| 66 | RIPK1 | 0.71927393 |
| 67 | RPS6KB2 | 0.71395027 |
| 68 | AKT2 | 0.70515708 |
| 69 | TNIK | 0.69465536 |
| 70 | ERBB2 | 0.66692202 |
| 71 | MAPK11 | 0.66526874 |
| 72 | PTK2 | 0.66425158 |
| 73 | MST1R | 0.63917706 |
| 74 | MAP3K11 | 0.63177960 |
| 75 | ALK | 0.62985646 |
| 76 | FER | 0.61608912 |
| 77 | ABL2 | 0.61590313 |
| 78 | TRIB3 | 0.58962400 |
| 79 | EIF2AK2 | 0.58195482 |
| 80 | CHEK1 | 0.57104836 |
| 81 | EPHA4 | 0.56613212 |
| 82 | CAMK2D | 0.55241605 |
| 83 | NLK | 0.53298341 |
| 84 | KSR2 | 0.50530481 |
| 85 | PDK1 | 0.50360740 |
| 86 | PAK1 | 0.48937679 |
| 87 | DYRK1B | 0.47572993 |
| 88 | DDR2 | 0.44936364 |
| 89 | NEK2 | 0.44300214 |
| 90 | ZAP70 | 0.43501784 |
| 91 | PRKCA | 0.42641393 |
| 92 | RET | 0.42544564 |
| 93 | TBK1 | 0.42006251 |
| 94 | AURKB | 0.41565906 |
| 95 | ITK | 0.40514133 |
| 96 | MTOR | 0.38752013 |
| 97 | DMPK | 0.38672467 |
| 98 | MAPK12 | 0.38560618 |
| 99 | PRKCD | 0.38236942 |
| 100 | YES1 | 0.36579894 |
| 101 | DYRK3 | 0.36438790 |
| 102 | IGF1R | 0.34932886 |
| 103 | JAK2 | 0.33371892 |
| 104 | CSNK1E | 0.32819696 |
| 105 | LATS2 | 0.32782241 |
| 106 | PRKCZ | 0.32084804 |
| 107 | PDGFRA | 0.31233734 |
| 108 | RPS6KA2 | 0.30373473 |
| 109 | IKBKE | 0.30049631 |
| 110 | BMX | 0.29959079 |
| 111 | TAOK1 | 0.29697670 |
| 112 | FYN | 0.29221203 |
| 113 | CDK2 | 0.29204218 |
| 114 | MET | 0.28624291 |
| 115 | IKBKB | 0.27994870 |
| 116 | FRK | 0.27816714 |
| 117 | MAP3K9 | 0.25953680 |
| 118 | AURKA | 0.23942289 |
| 119 | PRKACG | 0.23529490 |
| 120 | CDK6 | 0.23174112 |
| 121 | CHUK | 0.23064031 |
| 122 | BUB1 | 0.22604948 |
| 123 | IRAK1 | 0.22212886 |
| 124 | CAMK2G | 0.22069128 |
| 125 | RPS6KC1 | 0.21958782 |
| 126 | RPS6KL1 | 0.21958782 |
| 127 | PIM1 | 0.21899323 |
| 128 | MAP2K1 | 0.21008118 |
| 129 | INSR | 0.20225501 |
| 130 | CSNK1A1 | 0.20190181 |
| 131 | MAP3K8 | 0.20039994 |
| 132 | CDK4 | 0.20038349 |
| 133 | PRKCQ | 0.19661738 |
| 134 | MAP3K14 | 0.19511160 |
| 135 | PRKAA1 | 0.19337526 |
| 136 | ATM | 0.19211865 |
| 137 | FGR | 0.19187313 |
| 138 | BMPR2 | 0.19133497 |
| 139 | NME2 | 0.19015126 |
| 140 | LYN | 0.18980777 |
| 141 | LRRK2 | 0.18577324 |
| 142 | MAPKAPK3 | 0.18300327 |
| 143 | JAK1 | 0.18254991 |
| 144 | GSK3A | 0.17509482 |
| 145 | NEK1 | 0.17471920 |
| 146 | PRKACB | 0.16365722 |
| 147 | ICK | 0.15032274 |
| 148 | BLK | 0.14391516 |
| 149 | PRKAA2 | 0.14159342 |
| 150 | GSK3B | 0.13687970 |
| 151 | EPHB2 | 0.12746468 |
| 152 | MAPKAPK2 | 0.12697263 |
| 153 | PAK3 | 0.12440900 |
| 154 | MAPK1 | 0.11896762 |
| 155 | STK38L | 0.11339064 |
| 156 | STK38 | 0.11337958 |
| 157 | MAPK14 | 0.10994035 |
| 158 | SRC | 0.10980017 |
| 159 | CDK1 | 0.10651223 |
| 160 | CDK15 | 0.09840730 |
| 161 | MAPK4 | 0.09816268 |
| 162 | MAPK10 | 0.09585256 |
| 163 | DYRK1A | 0.09528635 |
| 164 | PRKACA | 0.09389926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.06262775 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.92455921 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 4.47291663 |
| 4 | Galactose metabolism_Homo sapiens_hsa00052 | 3.12881461 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.11478631 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.07179695 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.02924793 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.88031156 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.84565760 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.71387604 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.65849501 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53596585 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.45612965 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.34900048 |
| 15 | Thyroid cancer_Homo sapiens_hsa05216 | 1.72223214 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69593813 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66867741 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.54208687 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.52202270 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.46575731 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43025409 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.40070902 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39058677 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.38067120 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36072132 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35483983 |
| 27 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.30880869 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.27866112 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25309278 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22623908 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.19743236 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14991157 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13454239 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12232984 |
| 35 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11201612 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08930531 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08755387 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06884458 |
| 39 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.04898084 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01137668 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00505917 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00225976 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 0.99621247 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 0.96725303 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94878898 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93232936 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 0.91445916 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90952609 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90692982 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89130064 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 0.88544839 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87228615 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85245443 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84559551 |
| 55 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.83480140 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82346529 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79164095 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77439264 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76145861 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76135277 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.75666652 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72993854 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.72708369 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72383558 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72066135 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69901107 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67980812 |
| 68 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67238585 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67069906 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64808158 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64783980 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63656558 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63505834 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61936242 |
| 75 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60226276 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60043666 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59614481 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58663931 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55790268 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55665171 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54861106 |
| 82 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53630420 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53413123 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52741950 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52018429 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.51358473 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51162593 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50389384 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49148536 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49053550 |
| 91 | DNA replication_Homo sapiens_hsa03030 | 0.48514246 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48081968 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46692195 |
| 94 | Mismatch repair_Homo sapiens_hsa03430 | 0.46457668 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46101384 |
| 96 | Cell cycle_Homo sapiens_hsa04110 | 0.45932273 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45624204 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.43214440 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43028177 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41411834 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.41356074 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41307693 |
| 103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41023698 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39476922 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.39091284 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38426730 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38241370 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37380485 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36177073 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35985163 |
| 111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35965619 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35922569 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35403709 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.34675424 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33339698 |
| 116 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33153222 |
| 117 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32370608 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.32343576 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30758459 |
| 120 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30579202 |
| 121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29585010 |
| 122 | RNA degradation_Homo sapiens_hsa03018 | 0.29582517 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.28047956 |
| 124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27861974 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.26512283 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26442580 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24268448 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23992741 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.23928812 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.21822519 |
| 131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.20390986 |
| 132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.20386280 |
| 133 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19460328 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19327669 |
| 135 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.19178412 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17299534 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16515572 |
| 138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.15665958 |
| 139 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.10241180 |
| 140 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.09525261 |
| 141 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.08470025 |
| 142 | Influenza A_Homo sapiens_hsa05164 | 0.08029187 |
| 143 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.07715757 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.06829267 |
| 145 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.05664276 |
| 146 | Tuberculosis_Homo sapiens_hsa05152 | 0.05236232 |
| 147 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.04382203 |
| 148 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.03274626 |
| 149 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.03105674 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.02271104 |

